Clinical Trials

임상시험 트래커

국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.

7,301 trials30 companiesClinicalTrials.gov ↗

Photo Jan Folwarczny / Unsplash

15 results

1/2상모집 중· Sarcoma
진행성 육종 환자에서 리스부타투그 레제테칸의 유효성 및 안전성 평가 연구 (EMBOLD Sarcoma-202)
A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
리드: GSK
상세 →NCT07602777
1/2상모집 중· Respiratory Syncytial Virus Infections+Metapneumovirus
젊은 성인과 노년 성인에서 시험용 RSV/hMPV 조합 및 hMPV 백신 연구
A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults
리드: GSK
상세 →NCT07628049
1/2상모집 중· Neoplasms, Prostate
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
리드: GSK
상세 →NCT07332455
1/2상모집 중· Gastrointestinal Cancer
A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
협력: GSK
상세 →NCT07263594
1/2상모집 중· Neoplasms, Colorectal
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
리드: GSK
상세 →NCT07213609
1/2상모집 중· Neoplasms, Prostate
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
리드: GSK
상세 →NCT06990880
1/2상모집 중· Gastrointestinal Neoplasms
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
리드: GSK
상세 →NCT06885034
1/2상모집 중· Tumours, Gynecological
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
리드: GSK
상세 →NCT06796907
1/2상모집 중· Urinary Tract Infections
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
리드: GSK
상세 →NCT06702449
1/2상모집 중· Ovarian Cancer
A Study of Niraparib in Combination With Abemaciclib for Late Line Treatment of Ovarian Cancer (NICHOL TRIAL)
협력: GSK, 일라이 릴리
상세 →NCT06594679
1/2상모집 중· Myeloid Leukemia
A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia
협력: GSK
상세 →NCT06235801
1/2상모집 중· AL Amyloidosis
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
협력: GSK
상세 →NCT05145816
1/2상모집 중· Multiple Myeloma
A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma
협력: GSK
상세 →NCT05573802
1/2상모집 중· Multiple Myeloma
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
리드: GSK
상세 →NCT05714839
1/2상모집 중· Herpes Zoster
A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant
리드: GSK
상세 →NCT04006808

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.